https://hk.marketscreener.com/news/sino-biopharmaceutical-s-culmerciclib-capsule-receives-nmpa-approval-for-first-line-hr-her2-advanc-ce7f58ddd18dff25
Sino Biopharmaceutical's Culmerciclib capsule receives NMPA approval for first-line HR+/HER2-...
May 6, 2026 - Sino Biopharmaceutical Ltd: Culmerciclib capsule receives NMPA approval for first-line HR+/HER2- advanced breast cancer in China Culmerciclib receives second...